Effect of Glyburide on Glycemic Control, Insulin Requirement, and Glucose Metabolism in Insulin-Treated Diabetic Patients

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Diabetes

• Publication date

  1987-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diab.36.2.136PMID 3100365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.

  2009cited by this paper
• Glipizide versus tolbutamide, an open trial

  2005cited by this paper
• Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.

  1985cited by this paper
• Adjuvant Therapy with Tolazamide and Insulin Improves Metabolic Control in Type I Diabetes Mellitus

  1985cited by this paper
• Improved Insulin Sensitivity in Patients with Type I Diabetes Mellitus After CSII

  1985cited by this paper
• Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.

  1985cited by this paper
• Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo.

  1985cited by this paper
• The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.

  1984cited by this paper
• Cellular loci of sulfonylurea actions.

  1984cited by this paper
• Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal.

  1984cited by this paper
• The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects

  1984influential reference
• Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.

  1984cited by this paper
• Modulation by a Sulfonylurea of Insulin-dependent Glycogenesis, but Not of Insulin Binding, in Cultured Rat Hepatocytes: Evidence for a Postreceptor Mechanism of Action

  1984cited by this paper
• The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.

  1984cited by this paper
• Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

  1984cited by this paper
• Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.

  1984cited by this paper
• Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy

  1984cited by this paper
• Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.

  1984cited by this paper
• New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.

  1983cited by this paper
• Calculation of substrate oxidation rates in vivo from gaseous exchange.

  1983cited by this paper
• Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man

  1983cited by this paper
• The effect of glibenclamide on insulin receptors in normal man: comparative studies of insulin binding to monocytes and erythrocytes.

  1983cited by this paper
• Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase.

  1983cited by this paper
• Extrapancreatic effects of sulfonylureas. Potentiation of insulin action through post-binding mechanisms.

  1983cited by this paper
• Effect of Sulfonylurea Treatment on In Vivo Insulin Secretion and Action in Patients With Non-insulin-dependent Diabetes Mellitus

  1982cited by this paper
• The Effect of Graded Doses of Insulin on Total Glucose Uptake, Glucose Oxidation, and Glucose Storage in Man

  1982cited by this paper
• Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus

  1982cited by this paper
• Sulfonylureas Do Not Affect Insulin Binding or Glycemic Control in Insulin-dependent Diabetics

  1982cited by this paper
• Insulin secretion, insulin resistance, and obesity.

  1982cited by this paper
• Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus

  1982cited by this paper
• The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes

  1982cited by this paper
• In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.

  1981cited by this paper
• Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.

  1981cited by this paper
• Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

  1981cited by this paper
• The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization

  1981cited by this paper
• Clinical Pharmacology of Sulphonylurea Hypoglycaemic Agents: Part 2

  1981cited by this paper
• Clinical Pharmacology of Sulphonylurea Hypoglycaemic Agents: Part 1

  1981cited by this paper
• Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.

  1980cited by this paper
• Effects of dietary changes on cellular insulin binding and in vivo insulin sensitivity.

  1980cited by this paper
• Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islets

  1980cited by this paper
• Stimulation of residual insulin secretion by glibenclamide in insulin dependent diabetics.

  1980cited by this paper
• Sulfonylurea treatment of insulin-independent diabetes mellitus.

  1980cited by this paper
• Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.

  1979cited by this paper
• Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects.

  1979cited by this paper
• Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction.

  1978cited by this paper
• Sulphonylureas increase the number of insulin receptors

  1978cited by this paper
• Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide

  1977cited by this paper
• Extrapancreatic and pancreatic actions of glibenclamide in rats

  1977cited by this paper
• Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.

  1977cited by this paper
• The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal

  1977cited by this paper
• Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics

  1977cited by this paper
• Pancreatic action of the sulfonylureas.

  1977cited by this paper
• The Kinetics of Electrical Activity of Beta Cells in Response to a "Square Wave" Stimulation with Glucose or Glibenclamide*

  1976cited by this paper
• Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.

  1976cited by this paper
• Glucose turnover values in the dog obtained with various species of labeled glucose.

  1975cited by this paper
• Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.

  1974cited by this paper
• An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals

  1974cited by this paper
• Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems.

  1974cited by this paper
• The stimulus-secretion coupling of glucose-induced insulin release XII. Effects of diazoxide and gliclazide upon45calcium efflux from perifused islets

  1973cited by this paper
• Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect.

  1973cited by this paper
• Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.

  1972cited by this paper
• Effect of sulfonylureas on calcium uptake and insulin secretion by islets of Langerhans.

  1971cited by this paper
• Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method.

  1971cited by this paper
• Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes.

  1970cited by this paper
• The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

  1968cited by this paper
• Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.

  1967cited by this paper
• Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

  1967cited by this paper
• Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood.

  1962cited by this paper
• Compounds administered orally in the treatment of diabetes mellitus.

  1960cited by this paper
• Comparison of Plasma Insulin Levels Following Administration of Tolbutamide and Glucose

  1960cited by this paper
• CLINICAL AND EXPERIMENTAL STUDIES OF INSULIN SECRETION FOLLOWING TOLBUTAMIDE AND METAHEXAMIDE ADMINISTRATION

  1959cited by this paper
• INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT *

  1959cited by this paper
• ACTION OF THE HYPOGLYCEMIC SULFONYL COMPOUNDS IN HYPOPHYSECTOMIZED, ADRENALECTOMIZED, AND DEPANCREATIZED ANIMALS

  1957cited by this paper
• THE HYPOGLYCEMIC SULFONAMIDES: HISTORY AND DEVELOPMENT OF THE PROBLEM FROM 1942 TO 1955

  1957cited by this paper
• ANIMAL CALORIMETRY Twenty-Eighth Paper. THE RESPIRATORY METABOLISM OF A YOUNG PIG AS INFLUENCED BY FOOD AND BENZOIC ACID

  1924cited by this paper

• Non-insulin pharmacological therapies for treating type 1 diabetes

  2018cites this paper
• Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.

  2016cites this paper
• Sulfonylureas and meglitinides: insights into physiology and translational clinical utility

  2015cites this paper
• Use of Non-Insulin Therapies for Type 1 Diabetes

  2013cites this paper
• Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.

  2004cites this paper
• Sulfonylureas: Basic Aspects and Clinical Uses

  2004cites this paper
• Diabetes mellitus and pharmacological therapy.

  2003cites this paper
• Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.

  2002cites this paper
• Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure.

  2001cites this paper
• Mechanisms of acute and chronic hypoglycemic action of gliclazide

  2000cites this paper
• Pathophysiology and pharmacological treatment of insulin resistance.

  2000cites this paper
• The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus

  1999cites this paper
• Effect of adding a sulfonylurea in patients with non-insulin-dependent diabetes mellitus previously well controlled with insulin.

  1997cites this paper
• Glucose Toxicity and Insulin Resistance in NIDDM

  1997cites this paper
• Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.

  1996cites this paper
• Oral Antidiabetic Drug Use in the Elderly

  1996cites this paper
• Clinical utility of C-peptide measurement in diabetes mellitus.

  1996cites this paper
• Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.

  1996cites this paper
• Combined Therapy With a Sulfonylurea Plus Evening Insulin: Safe, Reliable, and Becoming Routine

  1996cites this paper
• Clinical Pharmacology of Sulfonylureas

  1996cites this paper
• Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM

  1995cites this paper
• Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure.

  1995cites this paper
• Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension.

  1994cites this paper
• The Effect of Glyburide on β-Cell Sensitivity to Glucose-Dependent Insulinotropic Polypeptide

  1993cites this paper
• Insulin Therapy in Type II Diabetes

  1993cites this paper
• The combination of insulin and oral hypoglycaemic drugs: a continuous challenge.

  1993cites this paper
• Mechanism(s) of the blood glucose lowering action of benfluorex.

  1993cites this paper
• Insulin Therapy and Weight Change in Native-American NIDDM patients

  1993cites this paper
• Combination Use of Sulfonylureas and Insulin in the Treatment of Noninsulin‐Dependent Diabetes Mellitus

  1992cites this paper
• Type II diabetes and syndrome X. Pathogenesis and glycemic management.

  1992cites this paper
• Effects of the combination of insulin and gliclazide compared with insulin alone in type 2 diabetic patients with secondary failure to oral hypoglycemic agents.

  1992cites this paper
• Management of the adult onset diabetic with sulfonylurea drug failure.

  1992cites this paper
• Treatment of Type I Diabetes with a Combination of Glyburide and Insulin

  1992cites this paper
• Glucose toxicity.

  1992cites this paper
• Pharmacological approach in the treatment of insulin resistance.

  1992cites this paper
• Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.

  1991cites this paper
• Patterns of Glucose and Lipid Abnormalities in Black NIDDM Subjects

  1991cites this paper
• Insulin plus a sulfonylurea agent for treating type 2 diabetes.

  1991cites this paper
• Combination of insulin and sulfonylureas: a literature review.

  1991cites this paper
• Hepatic sensitivity to insulin: effects of sulfonylurea drugs.

  1991cites this paper
• Rationale for the association of sulfonylurea and insulin.

  1991cites this paper
• Rationale for the association of sulfonylurea and insulin

  1991cites this paper
• Adjunctive Use of Tolazamide in Newly-Diagnosed Diabetic Children

  1990cites this paper
• [Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics].

  1990cites this paper
• Insulin Use in NIDDM

  1990cites this paper
• Low dose metformin in the treatment of type II non-insulin-dependent diabetes: Clinical and metabolic evaluations

  1990cites this paper
• Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus.

  1990cites this paper
• Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents

  1990cites this paper
• Combination Insulin-Sulfonylurea Therapy

  1990influential citation
• Combination of Insulin with Glipizide Increases Peripheral Glucose Disposal in Secondary Failure Type 2 Diabetic Patients

  1990cites this paper
• Effects of glyburide on in vivo insulin-mediated glucose disposal.

  1990cites this paper
• Treatment of NIDDM With Insulin Agonists or Substitutes

  1990cites this paper
• Underestimation of glucose turnover corrected with high-performance liquid chromatography purification of [6-3H]glucose.

  1990cites this paper
• [Physiopathology of non-insulin-dependent diabetes: current data and therapeutic consequences].

  1990cites this paper
• Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes

  1990cites this paper
• Physiopathologie du diabète non insulinodépendant : données actuelles et conséquences thérapeutiques

  1990cites this paper
• Use of Sulfonylurea Drugs in Elderly Patients

  1990cites this paper
• Combined Insulin-Sulfonylurea Therapy in Treatment of NIDDM

  1990influential citation
• Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic Subjects

  1989cites this paper
• Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas.

  1989cites this paper
• Oral hypoglycemic agents.

  1989cites this paper
• Effects of Combined Insulin-Sulfonylurea Therapy in type II Patients

  1989cites this paper
• Combined Insulin-Sulfonylurea Treatment of Type II Diabetes

  1989cites this paper
• Underestimation of Glucose Turnover Measured With [6-3H]- and [6,6-2 H2]- but not [6-14C]glucose During Hyperinsulinemia in Humans

  1989influential citation
• Sulphonylureas in the treatment of non-insulin-dependent diabetes.

  1989cites this paper
• Effect of glipizide on the surgically altered pancreas.

  1989cites this paper
• The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines.

  1988cites this paper
• Insulin‐glyburide combination therapy for non‐insulin‐dependent diabetes mellitus: A long‐term double‐blind, placebo‐controlled trial

  1988cites this paper
• Insulin treatment of non-insulin-dependent diabetes mellitus.

  1988cites this paper
• Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

  1988influential citation
• 12 Insulin treatment of non-insulin-dependent diabetes mellitus

  1988cites this paper
• Therapeutic dilemmas in type II diabetes mellitus--improving and maintaining beta-cell and insulin sensitivity.

  1988cites this paper
• Improved metabolic control in insulin-dependent diabetes mellitus with insulin and tolazamide.

  1988cites this paper
• The effects of hyperglycaemia on isotopic measurement of glucose utilisation using [23H], [33H] and [614C] glucose in patients with Type 1 (insulin-dependent) diabetes mellitus

  1987cites this paper
• Acute effect of glyburide on insulin sensitivity in type I diabetic patients.

  1987cites this paper
• Therapeutic Dilemmas in Type 11 Diabetes Mellitus-Improving and Maintaining fl-Cell and Insulin Sensitivity

  year unknowncites this paper